Ignite Creation Date:
2025-12-24 @ 9:27 PM
Ignite Modification Date:
2026-03-29 @ 6:28 PM
Study NCT ID:
NCT05222932
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-07
First Post:
2022-02-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
Sponsor:
Organization: